Asset Details
Do you wish to reserve the book?
Chapter 1: The Evolving Atrial Fibrillation Landscape: Importance of Early Diagnosis and Treatment
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chapter 1: The Evolving Atrial Fibrillation Landscape: Importance of Early Diagnosis and Treatment
Do you wish to request the book?
Chapter 1: The Evolving Atrial Fibrillation Landscape: Importance of Early Diagnosis and Treatment
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Chapter 1: The Evolving Atrial Fibrillation Landscape: Importance of Early Diagnosis and Treatment
2023
Overview
Chapter 1 begins with data that show the rising prevalence of atrial fibrillation (AF), which is increasing in tandem with the growing number of older adults, increased survival of people who have cardiovascular (CV) disorders, and the expanding use of wearable and insertable/implantable devices capable of detection. Together, these increases will result in healthcare providers seeing more patients with AF who present at earlier stages of the disease. The panel discussion covers information regarding symptoms that are common to patients with AF as well as information about the important adverse outcomes that may occur in patients with AF, including heart failure, hospitalization, thromboembolism, and death. Notably, these events may reflect either the comorbidities commonly underlying AF, AF itself, or a combination of these conditions. The chapter also introduces the four pillars of therapy—“upstream therapy,” rate control, rhythm control, and embolic prevention—with an emphasis on early rhythm control as being optimal. Chapter 1 is summarized as follows:(1)The prevalence of AF is increasing because of the aging population and people with CV comorbidities living longer; this will increase disease burden in the near future.(2)Wearable technology is resulting in earlier detection of AF, creating a larger unmet need.(3)Primary care providers and general cardiologists (non-interventional) will begin to see more patients with AF who will present at earlier stages of the disease.(4)Patients (even without symptoms) should be treated earlier to achieve rate optimization and rhythm control, to delay deterioration in quality of life, and to prevent disease progression, thus reducing the overall burden to the healthcare system.
Publisher
Elsevier Inc,Elsevier Limited
